Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 808.8516
- Book/Share 188.2509
- PB 2.0446
- Debt/Equity 0.7059
- CurrentRatio 1.4315
- ROIC 0.076
- MktCap 86722890400.0
- FreeCF/Share 16.2279
- PFCF 23.6045
- PE 14.6867
- Debt/Assets 0.2506
- DivYield 0.0172
- ROE 0.1394
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: May 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
ELV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: May 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
Law Offices of Frank R. Cruz Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action
Published: May 14, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action.
Read More
Securities Fraud Investigation Into Elevance Health, Inc. (ELV) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: May 14, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ELEVANCE HEALTH, INC. (ELV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Jul.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
Rosen Law Firm Urges Elevance Health, Inc. (NYSE: ELV) Stockholders to Contact the Firm for Information About Their Rights
Published: May 13, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024, and October 16, 2024. Elevance describes itself as a “healthcare company that provides health insurance plans to a variety of markets.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is.
Read More
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. (ELV)
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Indiana on behalf of all persons or entities who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) securities between April 18, 2024 and October 16, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company's investors under the federal securities laws.
Read More
10 Undervalued Dividend Growth Stocks: May 2025
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Positive
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.
Read More
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV continues to witness significant growth in Q1 revenues. However, its operating costs surge.
Read More
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Published: April 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Elevance Health, Inc. (NYSE:ELV ) Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwood - President, Government Health Benefits Pete Haytaian - President, Carelon Conference Call Participants A.J. Rice - UBS Lance Wilkes - Bernstein Stephen Baxter - Wells Fargo Andrew Mok - Barclays Lisa Gill - JPMorgan Ann Hynes - Mizuho Ryan Langston - TD Cowen Erin Wright - Morgan Stanley Ben Hendrix - RBC Capital Markets Josh Raskin - Nephron Research Sarah James - Cantor Fitzgerald Justin …
Read More
Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Elevance Health Reports First Quarter 2025 Results
Published: April 22, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results. “At Elevance Health, our purpose—to improve the health of humanity—drives everything we do. In the first quarter, we made measurable progress reimagining the healthcare experience with personalized support, real-time digital solutions, and a whole-health model that improves outcomes and reduces cost. Through Carelon and our broader enterprise, we're delivering on our strategy to be a lifetime t.
Read More
Health insurer Elevance sees first-quarter profit above estimates
Published: April 17, 2025 by: Reuters
Sentiment: Positive
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
Read More
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV's Q1 results are expected to reap the benefits of higher premiums from growing Medicare Advantage membership and acquisitions pursued within the Carelon unit.
Read More
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Published: April 08, 2025 by: Forbes
Sentiment: Positive
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare Advantage plans run by private insurers.
Read More
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
With a strengthening commercial business, ELV is seeing steady membership growth.
Read More
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Read More
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Negative
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact …
Read More
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Published: February 23, 2025 by: Seeking Alpha
Sentiment: Positive
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Ms. Gail Koziara Boudreaux
- Employees 104200